Feasibility and validity of the Patient Neurotoxicity Questionnaire during taxane chemotherapy in a phase III randomized trial in patients with breast cancer: N-SAS BC 02.

Source:http://linkedlifedata.com/resource/pubmed/id/19330359

Download in:

View as

General Info

PMID
19330359